Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hepion Pharmaceuticals Inc

HEPA
Current price
3.31 USD +0.31 USD (+10.33%)
Last closed 3.24 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 748 112 USD
Yield for 12 month +827.17 %
Week
Month
Year
HEPA
21.11.2021 - 28.11.2021

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in phase 2 clinical development for the treatment of non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837

Analytics

WallStreet Target Price

26 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures HEPA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -47 738 828 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -63.11 %
PEG Ratio
Return On Equity TTM -118.48 %
Wall Street Target Price 26 USD
Revenue TTM
Book Value 3.77 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -12.42 USD
Diluted Eps TTM -12.42 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics HEPA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HEPA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 11.05.2023
Dividend Date 03.06.2019

Stock Valuation HEPA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.0528
Price Book MRQ 1.0197

Financials HEPA

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators HEPA

For 52 weeks

2.55 USD 23.85 USD
50 Day MA 4.04 USD
Shares Short Prior Month 288 494
200 Day MA 9.36 USD
Short Ratio 5.55
Shares Short 331 675
Short Percent 7.84 %